INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 24 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,208,000 | -46.2% | 22,244,000 | -44.7% | 0.02% | -38.2% |
| Q4 2021 | $41,259,000 | +43.1% | 40,244,000 | +43.9% | 0.03% | +30.8% |
| Q3 2021 | $28,840,000 | +1003.7% | 27,975,000 | +1030.3% | 0.03% | +1200.0% |
| Q2 2021 | $2,613,000 | -6.5% | 2,475,000 | -1.0% | 0.00% | -33.3% |
| Q1 2021 | $2,796,000 | – | 2,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |